{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:18:27Z","timestamp":1777407507860,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203298"],"award-info":[{"award-number":["82203298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.122974","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T09:21:42Z","timestamp":1723540902000},"page":"122974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner"],"prefix":"10.1016","volume":"355","author":[{"given":"Jiahao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2024.122974_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.lfs.2024.122974_bb0010","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.21037\/tcr.2020.01.36","article-title":"Perioperative immunotherapy in muscle-invasive bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.122974_bb0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.lfs.2024.122974_bb0020","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jamaoncol.2021.3441","article-title":"Effect of cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma: a phase 2 randomized clinical trial","volume":"7","author":"Pal","year":"2021","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.lfs.2024.122974_bb0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.urolonc.2022.07.006","article-title":"Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: a scoping review","volume":"40","author":"Padua","year":"2022","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.lfs.2024.122974_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"7","key":"10.1016\/j.lfs.2024.122974_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urolonc.2018.04.010","article-title":"Metabolic changes in bladder cancer","volume":"36","author":"Woolbright","year":"2018","journal-title":"Urol. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122974_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030982","article-title":"Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy","volume":"15","author":"Afonso","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.lfs.2024.122974_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/0008-5472.CAN-21-0403","article-title":"PKM2 is essential for bladder cancer growth and maintenance","volume":"82","author":"Xia","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12967-022-03509-1","article-title":"Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer","volume":"20","author":"Huang","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2024.122974_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/OTT.S358008","article-title":"CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-dependent glycolysis reprogramming","volume":"15","author":"Li","year":"2022","journal-title":"Onco. Targets Ther."},{"issue":"2","key":"10.1016\/j.lfs.2024.122974_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41580-019-0179-2","article-title":"Molecular mechanisms and physiological importance of circadian rhythms","volume":"21","author":"Patke","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122974_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-981-15-6082-8_5","article-title":"Circadian clock regulation on lipid metabolism and metabolic diseases","volume":"1276","author":"Pan","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122974_bb0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ccell.2016.03.003","article-title":"An Arntl2-driven secretome enables lung adenocarcinoma metastatic self-sufficiency","volume":"29","author":"Brady","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.lfs.2024.122974_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214829120","article-title":"Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle","volume":"120","author":"Qu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12935-021-02046-z","article-title":"Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2024.122974_bb0085","article-title":"The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122974_bb0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41419-020-02839-6","article-title":"ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF\/BETA pathway and is regulated by miR-26a-5p","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.lfs.2024.122974_bb0095","first-page":"1293","article-title":"ARNTL2 knockdown suppressed the invasion and migration of colon carcinoma: decreased SMOC2-EMT expression through inactivation of PI3K\/AKT pathway","volume":"12","author":"Lu","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-024-01965-5","article-title":"Activation of the PI3K\/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib","volume":"23","author":"Ge","year":"2024","journal-title":"Mol. Cancer"},{"issue":"7501","key":"10.1016\/j.lfs.2024.122974_bb0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature13180","article-title":"Copper is required for oncogenic BRAF signalling and tumorigenesis","volume":"509","author":"Brady","year":"2014","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.lfs.2024.122974_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004303","article-title":"Copper promotes tumorigenesis by activating the PDK1-AKT oncogenic pathway in a copper transporter 1 dependent manner","volume":"8","author":"Guo","year":"2021","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122974_bb0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2024.122974_bb0120","first-page":"495","article-title":"Copper transporter-CTR1 expression and pathological outcomes in platinum-treated muscle-invasive bladder cancer patients","volume":"36","author":"Kilari","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2024.122974_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/03946320241240706","article-title":"Revealing the potential of solute carrier family 31 (copper transporters), member 1: insights into its role in bladder cancer progression and therapeutic implications","volume":"38","author":"Lin","year":"2024","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122974_bb0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.lfs.2024.122974_bb0135","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"He QY: clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13073-019-0704-0","article-title":"Genomics of circadian rhythms in health and disease","volume":"11","author":"Rijo-Ferreira","year":"2019","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-021-00577-7","article-title":"Circadian rhythms in neurodegenerative disorders","volume":"18","author":"Nassan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cen.14607","article-title":"Sleep, circadian rhythms, and type 2 diabetes mellitus","volume":"96","author":"Parameswaran","year":"2022","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122974_bb0155","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","article-title":"The emerging link between cancer, metabolism, and circadian rhythms","volume":"24","author":"Masri","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122974_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101562","article-title":"ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma","volume":"26","author":"Zhang","year":"2022","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122974_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12860-022-00450-5","article-title":"ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through inhibition of apoptosis and ferroptosis","volume":"24","author":"Wang","year":"2023","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122974_bb0170","series-title":"Pharmacogenomics and Personalized Medicine","first-page":"1425","article-title":"ARNTL2 is a prognostic biomarker and correlates with immune cell infiltration in triple-negative breast cancer","volume":"14","author":"Wang","year":"2021"},{"issue":"8","key":"10.1016\/j.lfs.2024.122974_bb0175","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","article-title":"Copper metabolism in cell death and autophagy","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2024.122974_bb0180","first-page":"19","article-title":"Copper depletion as a therapeutic strategy in cancer","author":"Lopez","year":"2019","journal-title":"Met. Ions Life Sci."},{"key":"10.1016\/j.lfs.2024.122974_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111634","article-title":"Copper in tumors and the use of copper-based compounds in cancer treatment","volume":"226","author":"da Silva","year":"2022","journal-title":"J. Inorg. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2024.122974_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","article-title":"Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma","volume":"22","author":"Tsang","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"22","key":"10.1016\/j.lfs.2024.122974_bb0195","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1158\/0008-5472.CAN-16-1190","article-title":"Copper chelation inhibits BRAF(V600E)-driven melanomagenesis and counters resistance to BRAF(V600E) and MEK1\/2 inhibitors","volume":"77","author":"Brady","year":"2017","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2024.122974_bb0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"Pt 3","key":"10.1016\/j.lfs.2024.122974_bb0205","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumor glycolysis, an essential sweet tooth of tumor cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"15","key":"10.1016\/j.lfs.2024.122974_bb0210","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1158\/0008-5472.CAN-20-3543","article-title":"ENO1 promotes lung cancer metastasis via HGFR and WNT signaling-driven epithelial-to-mesenchymal transition","volume":"81","author":"Li","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.122974_bb0215","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190503","article-title":"Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating \u03b2-catenin","volume":"39","author":"Ji","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2024.122974_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2021.09.027","article-title":"Upregulation of \u03b1 enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis","volume":"578","author":"Hou","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.122974_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1013035","article-title":"ENO1 contributes to 5-fluorouracil resistance in colorectal cancer cells via EMT pathway","volume":"12","author":"Gu","year":"2022","journal-title":"Front. Oncol."},{"issue":"14","key":"10.1016\/j.lfs.2024.122974_bb0230","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.7150\/ijbs.63556","article-title":"Enolase 1, a moonlighting protein, as a potential target for cancer treatment","volume":"17","author":"Qiao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2024.122974_bb0235","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.omto.2021.12.026","article-title":"ENO1 and cancer","volume":"24","author":"Huang","year":"2022","journal-title":"Mol. Ther. Oncol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:28:05Z","timestamp":1725755285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524005642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"alternative-id":["S0024320524005642"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122974","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122974"}}